Evaluation of ADG20 for the Prevention of COVID-19

NCT04859517 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
TERMINATED
Status
2582
Enrollment
INDUSTRY
Sponsor class

Stopped All primary efficacy data has been collected and analyzed. Based on the safety data gathered to date, it has been determined that continued participation by study subjects would not yield any additional beneficial safety information.

Conditions

Interventions

Sponsor

Invivyd, Inc.